Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

276 results about "Molecular cloning" patented technology

Molecular cloning is a set of experimental methods in molecular biology that are used to assemble recombinant DNA molecules and to direct their replication within host organisms. The use of the word cloning refers to the fact that the method involves the replication of one molecule to produce a population of cells with identical DNA molecules. Molecular cloning generally uses DNA sequences from two different organisms: the species that is the source of the DNA to be cloned, and the species that will serve as the living host for replication of the recombinant DNA. Molecular cloning methods are central to many contemporary areas of modern biology and medicine.

Method for preparing molecular cloning chip for high-throughput cloning of nucleic acid molecule

The invention provides a method for preparing a molecular cloning chip by cloning high flux nucleic acid molecule. The method comprises the following steps: a. a cloning nucleic acid molecule template is mixed with a nucleic acid amplification reaction system reagent to obtain an amplification mixture solution; b. the amplification mixture solution is added with a high molecular compound; c. the solution is added with oil phase, of which the volume is two times of the volume of the solution for emulsification to obtain water-in-oil emulsion; d. the emulsion is placed in a PCR meter or a thermostat to undergo a nucleic acid amplification reaction; e. after the nucleic acid amplification reaction, the emulsion is cooled down to form nucleic acid molecule cloning grains; f. the nucleic acid molecule cloning grains are separated; and g. the nucleic acid molecule cloning grains are randomly dispersed on a solid phase carrier to fix the nucleic acid amplification products in the solution on the solid phase carrier and form a nucleic acid molecule cloning array on the surface of the solid phase carrier and thus the cloning chip is obtained. The method has the advantages of improving preparation sequencing template, ensuring high flux of sequencing and lowering sequencing cost.
Owner:SOUTHEAST UNIV

Method for preparing molecular cloning chip for high-throughput cloning of nucleic acid molecule

The invention provides a method for preparing a molecular cloning chip by cloning high flux nucleic acid molecule. The method comprises the following steps: a. a cloning nucleic acid molecule template is mixed with a nucleic acid amplification reaction system reagent to obtain an amplification mixture solution; b. the amplification mixture solution is added with a high molecular compound; c. the solution is added with oil phase, of which the volume is two times of the volume of the solution for emulsification to obtain water-in-oil emulsion; d. the emulsion is placed in a PCR meter or a thermostat to undergo a nucleic acid amplification reaction; e. after the nucleic acid amplification reaction, the emulsion is cooled down to form nucleic acid molecule cloning grains; f. the nucleic acid molecule cloning grains are separated; and g. the nucleic acid molecule cloning grains are randomly dispersed on a solid phase carrier to fix the nucleic acid amplification products in the solution onthe solid phase carrier and form a nucleic acid molecule cloning array on the surface of the solid phase carrier and thus the cloning chip is obtained. The method has the advantages of improving preparation sequencing template, ensuring high flux of sequencing and lowering sequencing cost.
Owner:SOUTHEAST UNIV

Micro-arrayed organization of transcription factor target genes

The following invention outlines methodologies for the construction and utilization of transcription factor direct target gene microarrays of both DNA and corresponding protein/peptide target origin. The technology entails the array/microarray annotation and organization of transcription factor direct loci and corresponding protein products identified through modified and improved versions of chromosomal immunoprecipitation (CHIP) and molecular cloning procedures. It allows for the formulation of physiologically directed arrays which result in a thorough, focused characterization of the genetic and biochemical regulation occurring within a give population of cells or a given tissue. Arrays and microarrays of direct targets for any given transcription factor created utilizing this technology are substantially more clinically relevant for purposes of medical diagnostics and patient prognostics than conventional microarrays due to the physiologically focused nature and the transcription factor targets. In addition, the characterization and array organization of transcription factor target protein products and the assessment of their interactions with other proteins and/or small molecules is of critical importance for the purposes of understanding cellular and ultimately the design of therapeutics for human anomalies.
Owner:BURS JR ROBERT M +2

Method for extracting total ribonucleic acid from plants with polysaccharide and polyphenol by using silica membrane

ActiveCN102533737AImprove bindingInhibit RNase activityDNA preparationFiltrationSilica gel
The invention relates to a method for extracting total ribonucleic acid from plants with polysaccharide and polyphenol by using a silica membrane, and belongs to the field of nucleic acid purification. The method comprises the following steps of: adding a lysis solution for the plants with polysaccharide and polyphenol into a plant material with polysaccharide and polyphenol, which is ground by liquid nitrogen, performing centrifugal separation on the mixture, taking the supernate obtained through centrifugal separation out, transferring into a filtration column for filtration, adding absolute ethanol into filtrate, uniformly mixing, transferring into a silica membrane adsorbing column for adsorbing centrifugation, adding a protein removing solution and a deoxyribonuclease solution for protein removal centrifugation twice, adding a rinsing solution for desalting centrifugation, performing drying centrifugation, and adding deoxyribonuclease water for rinsing centrifugation to obtain a ribonucleic acid solution. The method has the characteristics of high efficiency, quickness and conciseness; and the purified ribonucleic acid (RNA) can be used for various downstream experiments suchas microarray analysis, in vitro translation, molecular cloning and the like.
Owner:TIANGEN BIOTECH BEIJING

Antigen-norovirus P-domain monomers and dimers, antigen-norovirus P-particle molecules, and methods for their making and use

A substituted Norovirus capsid protein monomer, having only the P-domain and called an antigen-Norovirus P-domain monomer, includes a foreign antigen inserted into one or more of three surface loops present on each P-domain monomer by molecular cloning. The antigen-P-domain monomer can assemble spontaneously into an octahedral form, called an antigen-Norovirus P-particle, that is composed of 24 copies of the antigen-P-domain monomer. Each substituted P-domain monomer will contain one to three copies of the foreign antigen, for a total of 24-72 antigen copies on each antigen-P-particle. The antigen-P-particle is useful in methods for diagnosing, immunizing and treating individuals infected with a foreign virus, for example Rotavirus, and can serve as a carrier for presentation of foreign antigens for development of novel vaccines against many infectious and non-infectious diseases. The substituted Norovirus P-particles can be readily produced in E. coli and yeast, are highly stable and tolerate a wide range of physio-chemical conditions. A modified Norovirus P-domain monomer includes one or more restriction recognition sites inserted within one or more of the three loops of the P-domain monomers, to provide user-friendly cloning cassettes for conveniently inserting candidate foreign antigens into the surface loops. The P-particle-VP8 chimeras may also serve as a dual vaccine against both rotavirus and norovirus.
Owner:CHILDRENS HOSPITAL MEDICAL CENT CINCINNATI

Replicative HBV (Hepatitis B Virus) vector carrying foreign gene and recombinant HBV generated after transfection and corresponding preparation method and application

ActiveCN103173492AGuaranteed high level of replicationPreserve the ability to reinfectMicroorganism based processesViruses/bacteriophagesHepatitis B virusVirus strain
The invention discloses a replicative HBV (Hepatitis B Virus) vector carrying a foreign gene and a recombinant HBV generated after transfection and a corresponding preparation method and an application. The vector separates overlaying genes C and P on an HBV genome by a molecular cloning technique based on originally expressed HBV plasmid to respectively form an integral opened reading frame where a protein translation starting sequence or a protease enzyme cutting site is inserted to respectively guide expression of foreign gene and gene P. The replicative HBV vector carrying the foreign gene transiently transfecting hepatoma carcinoma cell secretes the recombinant HBV. The recombinant HBV prepared from the HBV vector transfection cells provided by the invention can express the foreign gene and maintain the replicative and infecting capacity. The invention is suitable for constructing an HBV chronic infection animal model, an HBV cell model with cccDNA stably and automatically replicated and a traceable HBV strain, researching a molecular mechanism of HBV infection, replication, packaging and the like, and screening anti-HBV novel medicines.
Owner:BEIQIUEN INT PEACE HOSPITAL P L A
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products